| Literature DB >> 35297176 |
Patryk Łakuta1,2, Dagny Krankowska3, Przemysław Marcinkiewicz4, Monika Bociąga-Jasik5, Agnieszka Komorska-Błażewicz6.
Abstract
Effective antiretroviral treatment has increased the life expectancy of people living with HIV, and currently, the challenges of prominent importance appear to be mental health issues. This preregistered study among adults living with HIV/AIDS investigated the effectiveness of a brief self-affirmation intervention framed in terms of if-then plans (i.e. self-affirming implementation intentions [S-AII]) against both active and non-active control conditions, forming non-affirming implementation intentions and mere goal intentions, respectively. The primary outcomes were defined as a reduction of depressive symptoms and enhancement of well-being, along with secondary outcomes as positive other- and self-directed feelings. A total of 162 individuals were assessed for eligibility, and 130 (aged 18-74 years) were randomized to the study conditions. Intervention effects were estimated through intention-to-treat analysis, using linear mixed models. The S-AII intervention yielded improvements in overall well-being over 2 weeks (d = .23), primarily driven by positive changes in emotional (d = .24) and social (d = .30) dimensions of well-being. There were no significant differences in depression or secondary outcomes. Based on a minimal clinically important difference index, the S-AII intervention resulted in improvement in well-being in approximately 40 percent of participants. Nevertheless, further systematic research is needed to optimize self-affirmation-interventions, before their application in real-life contexts.Entities:
Keywords: HIV; depression; implementation intention; mental health; self-affirmation; well-being
Mesh:
Year: 2022 PMID: 35297176 PMCID: PMC9540674 DOI: 10.1111/aphw.12357
Source DB: PubMed Journal: Appl Psychol Health Well Being ISSN: 1758-0854
FIGURE 1CONSORT flow diagram: Enrollment, group randomization, attrition, and data analysis. MGI, mere goal intention condition; N‐AII, non‐affirming implementation intention condition; S‐AII, self‐affirming implementation intention condition
Baseline characteristics of participants in the trial (N = 130)
| MGI ( | S‐AII ( | N‐AII ( | Test statistics | |
|---|---|---|---|---|
| Demographics | ||||
| Age (years), | 41.07 (13.34) | 37.02 (11.83) | 40.23 (11.56) |
|
| Gender, |
| |||
| Female | 4 (9.3%) | 4 (9.3%) | 4 (9.1%) | |
| Male | 39 (90.7%) | 39 (90.7%) | 40 (90.9%) | |
| Marital status, |
| |||
| Married/cohabiting | 15 (34.9%) | 17 (39.5%) | 16 (36.4%) | |
| Not married (single, divorced, widowed) | 28 (65.1%) | 26 (60.5%) | 28 (63.6%) | |
| Education level (highest level completed), |
| |||
| Low (primary school, lower secondary) | 0 (0.0%) | 2 (4.7%) | 1 (2.3%) | |
| Intermediate (upper secondary education) | 18 (41.9%) | 17 (39.5%) | 12 (27.3%) | |
| High (tertiary education, university degree) | 25 (58.1%) | 24 (55.8%) | 31 (70.4%) | |
| Work status, |
| |||
| Student | 1 (2.3%) | 3 (7.0%) | 2 (4.6%) | |
| Paid employment | 35 (81.4%) | 37 (86.0%) | 36 (81.8%) | |
| Unemployed | 1 (2.3%) | 1 (2.3%) | 3 (6.8%) | |
| Pensioner or retired | 6 (14.0%) | 2 (4.7%) | 3 (6.8%) | |
| Health‐related characteristics | ||||
| Present general health, | 4.07 (0.83) | 4.14 (0.74) | 4.05 (0.78) |
|
| CD4+ cell counts, |
| |||
| <200 cells/μl | 6 (13.9%) | 9 (20.9%) | 4 (9.1%) | |
| 200–500 cells/μl | 11 (25.6%) | 13 (30.2%) | 16 (36.4%) | |
| >500 cells/μl | 26 (60.5%) | 21 (48.9%) | 24 (54.5%) | |
| HIV‐1 viremia, |
| |||
| Undetectable viral load | 38 (88.3%) | 36 (83.7%) | 42 (95.5%) | |
| 40–100,000 copies/ml | 2 (4.7%) | 5 (11.6%) | 2 (4.5%) | |
| >100,000 copies/ml | 3 (7.0%) | 2 (4.7%) | 0 (0.0%) | |
| Antiretroviral treatment duration in years, | 7.15 (6.93) | 6.16 (5.51) | 6.61 (6.23) |
|
| Primary outcomes | ||||
| PHQ‐9, | 4.49 (4.42) | 5.44 (4.45) | 5.66 (5.06) |
|
| Prevalence of depression, |
| |||
| No symptoms (PHQ‐9 ≤ 4) | 25 (58.2%) | 17 (39.5%) | 25 (56.8%) | |
| Mild symptoms (PHQ‐9 ≥ 5 and ≤9) | 13 (30.2%) | 17 (39.5%) | 9 (20.5%) | |
| Significant symptoms (PHQ‐9 ≥ 10) | 5 (11.6%) | 9 (21.0%) | 10 (22.7%) | |
| MHC‐SF (total score), | 38.49 (15.18) | 36.98 (15.92) | 37.55 (16.14) |
|
| MHC‐SF EW, | 7.81 (3.72) | 8.77 (4.39) | 8.91 (4.10) |
|
| MHC‐SF SW, | 10.79 (6.38) | 9.35 (5.70) | 9.93 (6.76) |
|
| MHC‐SF PW, | 19.88 (6.59) | 18.86 (7.23) | 18.70 (7.07) |
|
| Secondary outcomes | ||||
| Positive self‐directed feelings, | 17.86 (4.02) | 16.33 (4.36) | 16.32 (4.46) |
|
| Positive other‐directed feelings, | 18.35 (3.62) | 17.67 (3.99) | 17.23 (4.73) |
|
Abbreviations: EW, emotional well‐being subscale; MGI, mere goal intention condition; MHC‐SF, Mental Health Continuum—Short Form; N‐AII, non‐affirming implementation intention condition; PHQ‐9, nine‐item Patient Health Questionnaire; PW, psychological well‐being subscale; S‐AII, self‐affirming implementation intention condition; SW, social well‐being subscale.
Results of the LMM analysis for primary and secondary outcomes
| Overall well‐being | Depression | Positive self‐directed feelings | Positive other‐directed feelings | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimate ( |
|
|
| Estimate ( |
|
|
| Estimate ( |
|
|
| Estimate ( |
|
|
| |
| Intercept | 14.13 (10.73) | 130 | 1.32 | .190 | 11.32 (3.20) | 130 | 3.54 | <.001 | 13.03 (2.85) | 128 | 4.57 | <.001 | 17.95 (2.82) | 126 | 6.37 | <.001 |
| Gender | 5.43 (4.61) | 128 | 1.18 | .241 | −2.10 (1.37) | 128 | −1.53 | .127 | 0.78 (1.22) | 127 | 0.65 | .518 | −1.29 (1.21) | 124 | −1.07 | .287 |
| Age | 0.33 (0.11) | 132 | 3.01 | .003 | −0.05 (0.03) | 133 | −1.61 | .110 | 0.06 (0.03) | 132 | 1.95 | .053 | 0.06 (0.03) | 131 | 1.89 | .061 |
| Time | 0.01 (0.78) | 113 | 0.02 | .986 | −0.25 (0.30) | 115 | −0.85 | .396 | −0.02 (0.26) | 113 | −0.06 | .952 | −0.18 (0.28) | 111 | −0.62 | .534 |
| Condition: MGI vs. SA‐II, NA‐II | 0.42 (2.88) | 147 | 0.14 | .885 | −0.93 (0.88) | 158 | −1.07 | .288 | 0.87 (0.75) | 130 | 1.16 | .247 | 0.43 (0.74) | 128 | 0.58 | .562 |
| Condition: SA‐II vs. NA‐II | 0.51 (3.32) | 147 | 0.16 | .877 | −0.40 (1.01) | 158 | −0.39 | .698 | 0.56 (0.86) | 130 | 0.66 | .512 | 0.73 (0.85) | 128 | 0.86 | .390 |
| Time × condition: MGI vs. SA‐II, NA‐II | −2.60 (1.66) | 113 | −1.57 | .120 | 0.10 (0.63) | 115 | 0.17 | .868 | −1.06 (0.56) | 113 | −1.89 | .061 | −0.67 (0.60) | 111 | −1.11 | .268 |
| Time × condition: SA‐II vs. NA‐II | 4.53 (1.90) | 113 | 2.39 | .019 | −0.35 (0.72) | 115 | −0.48 | .630 | 0.74 (0.65) | 113 | 1.15 | .255 | 0.22 (0.69) | 111 | 0.32 | .749 |
Abbreviations: df, degrees of freedom (Satterthwaite method for degrees of freedom); LMM, linear mixed model; MGI, mere goal intention condition; N‐AII, non‐affirming implementation intention condition; S‐AII, self‐affirming implementation intention condition.
Results of the LMM analysis for three dimensions of well‐being
| Psychological well‐being | Emotional well‐being | Social well‐being | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimate ( |
|
|
| Estimate ( |
|
|
| Estimate ( |
|
|
| |
| Intercept | 7.61 (4.73) | 129 | 1.61 | .110 | 2.16 (2.64) | 130 | 0.82 | .415 | 4.35 (4.28) | 129 | 1.02 | .311 |
| Gender | 3.06 (2.03) | 128 | 1.51 | .134 | 1.22 (1.14) | 128 | 1.08 | .285 | 1.15 (1.84) | 128 | 0.63 | .533 |
| Age | 0.14 (0.05) | 133 | 2.83 | .005 | 0.10 (0.03) | 134 | 3.80 | <.001 | 0.09 (0.04) | 132 | 2.07 | .040 |
| Time | −0.44 (0.39) | 114 | −1.11 | .268 | 0.18 (0.24) | 115 | 0.76 | .451 | 0.28 (0.35) | 113 | 0.79 | .430 |
| Condition: MGI vs. SA‐II, NA‐II | −0.07 (1.24) | 131 | −0.06 | .957 | −1.12 (0.69) | 132 | −1.62 | .108 | 0.30 (1.12) | 131 | 0.27 | .788 |
| Condition: SA‐II vs. NA‐II | 1.08 (1.42) | 131 | 0.76 | .449 | 0.97 (0.80) | 132 | 1.22 | .223 | 0.71 (1.29) | 131 | 0.55 | .583 |
| Time × condition: MGI vs. SA‐II, NA‐II | −1.67 (0.84) | 114 | −1.99 | .050 | 0.32 (0.50) | 115 | 0.64 | .526 | −1.25 (0.75) | 113 | −1.67 | .097 |
| Time × condition: SA‐II vs. NA‐II | 0.95 (9.96) | 114 | 0.99 | .326 | 1.56 (0.58) | 115 | 2.71 | .008 | 1.99 (0.86) | 113 | 2.32 | .022 |
Abbreviations: df, degrees of freedom (Satterthwaite method for degrees of freedom); LMM, linear mixed model; MGI, mere goal intention condition; N‐AII, non‐affirming implementation intention condition; S‐AII, self‐affirming implementation intention condition.
MCID proportions in well‐being and depressive symptoms across the three study conditions
| MGI ( | S‐AII ( | N‐AII ( | Test statistics | |
|---|---|---|---|---|
| MCID on the MHC‐SF scores |
| |||
| Improvement, | 6 (16.7%) | 15 (40.5%) | 4 (10.8%) | |
| No change, | 18 (50.0%) | 18 (48.7%) | 24 (64.9%) | |
| Deterioration, | 12 (33.3%) | 4 (10.8%) | 9 (24.3%) | |
| MCID on the PHQ‐9 scores |
| |||
| Improvement, | 3 (8.3%) | 9 (24.3%) | 5 (13.5%) | |
| No change, | 31 (86.1%) | 23 (62.2%) | 28 (75.7%) | |
| Deterioration, | 2 (5.6%) | 5 (13.5%) | 4 (10.8%) |
Note. Results are based on complete case analysis.
Abbreviations: MCID, minimal clinically important difference; MGI, mere goal intention condition; MHC‐SF, Mental Health Continuum—Short Form; N‐AII, non‐affirming implementation intention condition; PHQ‐9, nine‐item Patient Health Questionnaire; S‐AII, self‐affirming implementation intention condition.